カテゴリー： QYResearch, 世界

アデノ随伴ウイルス遺伝子治療の世界市場2026年

【英語タイトル】Global Adeno-Associated Virus Gene Therapy Market Research Report 2026

QYResearchが出版した調査資料（QYR8003HN8835）・商品コード：QYR8003HN8835
・発行会社（調査会社）：QYResearch
・発行日：2026年6月
・ページ数：130
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥452,400見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD4,350 ⇒換算￥678,600見積依頼/購入/質問フォーム
Corporate License（閲覧人数無制限）USD5,800 ⇒換算￥904,800見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

世界のアデノ随伴ウイルス（AAV）遺伝子治療市場は、2025年に18億3800万米ドルと評価され、2026年から2032年にかけて年平均成長率（CAGR）7.5％で拡大し、2032年には30億2700万米ドルに達すると予測されています。

北米のアデノ随伴ウイルス遺伝子治療市場は、2025年のUS$ millionから2032年までにUS$ millionへと拡大し、2026年から2032年にかけて年平均成長率（CAGR）%で成長すると予測されています。

アジア太平洋地域のアデノ随伴ウイルス遺伝子治療市場は、2025年のUS$ millionから2032年にはUS$ millionへと拡大し、2026年から2032年にかけて%のCAGRで成長すると予測されています。

病院におけるアデノ随伴ウイルス遺伝子治療の世界市場は、2025年のUS$ millionから2032年にはUS$ millionへと拡大し、2026年から2032年にかけて年平均成長率（CAGR）%で成長すると推定されています。

アデノ随伴ウイルス（AAV）遺伝子治療分野の主要なグローバル企業には、Creative Biolabs、Affinia Therapeutics、Spark Therapeutics、AGC Biologics、StrideBio、SIRION Biotech、Neurophth Biotechnology、Belief BioMed、BiBo Biopharma Engineering Co., Ltd.、北海康成などが含まれる。2025年時点で、世界の売上高の約％を上位3社が占めていた。

本レポートは、アデノ随伴ウイルス（AAV）遺伝子治療の世界市場に関する包括的な概要を、定量的および定性的な分析とともに提供し、読者が成長戦略を策定し、競争環境を評価し、現在の市場における自社の位置づけを把握し、アデノ随伴ウイルス（AAV）遺伝子治療に関する情報に基づいたビジネス上の意思決定を行うことを支援するものである。アデノ随伴ウイルス遺伝子治療市場の規模、推計値、および予測は、売上高（百万米ドル）ベースで提示されており、2025年を基準年とし、2021年から2032年までの過去データおよび予測データが含まれています。

本レポートは、世界のアデノ随伴ウイルス遺伝子治療市場を包括的にセグメント化しています。タイプ別、用途別、および企業別の地域別市場規模も提供されています。より深い洞察を得るため、本レポートでは競争環境、主要競合他社、およびそれぞれの市場順位を分析し、技術動向や新製品開発について論じています。

本レポートは、アデノ随伴ウイルス遺伝子治療のメーカー、新規参入企業、および業界バリューチェーン全体の企業に対し、市場全体およびそのサブセグメントごとの売上高、販売数量、平均価格に関する情報を、企業別、タイプ別、用途別、地域別に提供することで支援します。

タイプ別セグメント

遺伝子サイレンシング
遺伝子置換
遺伝子導入
遺伝子編集

用途別セグメント

病院
研究機関
その他

企業別分析

Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., Ltd.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio

The global Adeno-Associated Virus Gene Therapy market was valued at US$ 1838 million in 2025 and is anticipated to reach US$ 3027 million by 2032, at a CAGR of 7.5% from 2026 to 2032.

The North American market for Adeno-Associated Virus Gene Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Adeno-Associated Virus Gene Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Adeno-Associated Virus Gene Therapy in Hospitals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Adeno-Associated Virus Gene Therapy include Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed, BiBo Biopharma Engineering Co., Ltd., Beihai Kangcheng, etc. In 2025, the world’s top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Adeno-Associated Virus Gene Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Adeno-Associated Virus Gene Therapy. The Adeno-Associated Virus Gene Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Adeno-Associated Virus Gene Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Adeno-Associated Virus Gene Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Segment by Type

Gene Silencing
Gene Replacement
Gene Addition
Gene Editing

Segment by Application

Hospitals
Research Institute
Others

By Company

Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., Ltd.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio

❖ レポートの目次 ❖

1. Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Gene Silencing

1.2.3 Gene Replacement

1.2.4 Gene Addition

1.2.5 Gene Editing

1.3 Market by Application

1.3.1 Global Adeno-Associated Virus Gene Therapy Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals

1.3.3 Research Institute

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2. Global Growth Trends

2.1 Global Adeno-Associated Virus Gene Therapy Market Perspective (2021–2032)

2.2 Global Adeno-Associated Virus Gene Therapy Growth Trends by Region

2.2.1 Global Adeno-Associated Virus Gene Therapy Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Adeno-Associated Virus Gene Therapy Historic Market Size by Region (2021–2026)

2.2.3 Adeno-Associated Virus Gene Therapy Forecasted Market Size by Region (2027–2032)

2.3 Adeno-Associated Virus Gene Therapy Market Dynamics

2.3.1 Adeno-Associated Virus Gene Therapy Industry Trends

2.3.2 Adeno-Associated Virus Gene Therapy Market Drivers

2.3.3 Adeno-Associated Virus Gene Therapy Market Challenges

2.3.4 Adeno-Associated Virus Gene Therapy Market Restraints

3. Competition Landscape by Key Players

3.1 Global Top Adeno-Associated Virus Gene Therapy Players by Revenue

3.1.1 Global Top Adeno-Associated Virus Gene Therapy Players by Revenue (2021–2026)

3.1.2 Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Players (2021–2026)

3.2 Global Top Adeno-Associated Virus Gene Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Adeno-Associated Virus Gene Therapy Revenue

3.4 Global Adeno-Associated Virus Gene Therapy Market Concentration Ratio

3.4.1 Global Adeno-Associated Virus Gene Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Adeno-Associated Virus Gene Therapy Revenue in 2025

3.5 Global Key Players of Adeno-Associated Virus Gene Therapy Head Offices and Areas Served

3.6 Global Key Players of Adeno-Associated Virus Gene Therapy, Products and Applications

3.7 Global Key Players of Adeno-Associated Virus Gene Therapy, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4. Adeno-Associated Virus Gene Therapy Breakdown Data by Type

4.1 Global Adeno-Associated Virus Gene Therapy Historic Market Size by Type (2021–2026)

4.2 Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Type (2027–2032)

5. Adeno-Associated Virus Gene Therapy Breakdown Data by Application

5.1 Global Adeno-Associated Virus Gene Therapy Historic Market Size by Application (2021–2026)

5.2 Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Application (2027–2032)

6. North America

6.1 North America Adeno-Associated Virus Gene Therapy Market Size (2021–2032)

6.2 North America Adeno-Associated Virus Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Adeno-Associated Virus Gene Therapy Market Size by Country (2021–2026)

6.4 North America Adeno-Associated Virus Gene Therapy Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7. Europe

7.1 Europe Adeno-Associated Virus Gene Therapy Market Size (2021–2032)

7.2 Europe Adeno-Associated Virus Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2021–2026)

7.4 Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8. Asia-Pacific

8.1 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size (2021–2032)

8.2 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2021–2026)

8.4 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9. Latin America

9.1 Latin America Adeno-Associated Virus Gene Therapy Market Size (2021–2032)

9.2 Latin America Adeno-Associated Virus Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2021–2026)

9.4 Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10. Middle East & Africa

10.1 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size (2021–2032)

10.2 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2021–2026)

10.4 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11. Key Players Profiles

11.1 Creative Biolabs

11.1.1 Creative Biolabs Company Details

11.1.2 Creative Biolabs Business Overview

11.1.3 Creative Biolabs Adeno-Associated Virus Gene Therapy Introduction

11.1.4 Creative Biolabs Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.1.5 Creative Biolabs Recent Development

11.2 Affinia Therapeutics

11.2.1 Affinia Therapeutics Company Details

11.2.2 Affinia Therapeutics Business Overview

11.2.3 Affinia Therapeutics Adeno-Associated Virus Gene Therapy Introduction

11.2.4 Affinia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.2.5 Affinia Therapeutics Recent Development

11.3 Spark Therapeutics

11.3.1 Spark Therapeutics Company Details

11.3.2 Spark Therapeutics Business Overview

11.3.3 Spark Therapeutics Adeno-Associated Virus Gene Therapy Introduction

11.3.4 Spark Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.3.5 Spark Therapeutics Recent Development

11.4 AGC Biologics

11.4.1 AGC Biologics Company Details

11.4.2 AGC Biologics Business Overview

11.4.3 AGC Biologics Adeno-Associated Virus Gene Therapy Introduction

11.4.4 AGC Biologics Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.4.5 AGC Biologics Recent Development

11.5 StrideBio

11.5.1 StrideBio Company Details

11.5.2 StrideBio Business Overview

11.5.3 StrideBio Adeno-Associated Virus Gene Therapy Introduction

11.5.4 StrideBio Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.5.5 StrideBio Recent Development

11.6 SIRION Biotech

11.6.1 SIRION Biotech Company Details

11.6.2 SIRION Biotech Business Overview

11.6.3 SIRION Biotech Adeno-Associated Virus Gene Therapy Introduction

11.6.4 SIRION Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.6.5 SIRION Biotech Recent Development

11.7 Neurophth Biotechnology

11.7.1 Neurophth Biotechnology Company Details

11.7.2 Neurophth Biotechnology Business Overview

11.7.3 Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Introduction

11.7.4 Neurophth Biotechnology Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.7.5 Neurophth Biotechnology Recent Development

11.8 Belief BioMed

11.8.1 Belief BioMed Company Details

11.8.2 Belief BioMed Business Overview

11.8.3 Belief BioMed Adeno-Associated Virus Gene Therapy Introduction

11.8.4 Belief BioMed Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.8.5 Belief BioMed Recent Development

11.9 BiBo Biopharma Engineering Co., Ltd.

11.9.1 BiBo Biopharma Engineering Co., Ltd. Company Details

11.9.2 BiBo Biopharma Engineering Co., Ltd. Business Overview

11.9.3 BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Introduction

11.9.4 BiBo Biopharma Engineering Co., Ltd. Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.9.5 BiBo Biopharma Engineering Co., Ltd. Recent Development

11.10 Beihai Kangcheng

11.10.1 Beihai Kangcheng Company Details

11.10.2 Beihai Kangcheng Business Overview

11.10.3 Beihai Kangcheng Adeno-Associated Virus Gene Therapy Introduction

11.10.4 Beihai Kangcheng Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.10.5 Beihai Kangcheng Recent Development

11.11 PackGene Biotech

11.11.1 PackGene Biotech Company Details

11.11.2 PackGene Biotech Business Overview

11.11.3 PackGene Biotech Adeno-Associated Virus Gene Therapy Introduction

11.11.4 PackGene Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.11.5 PackGene Biotech Recent Development

11.12 Sarepta Therapeutics

11.12.1 Sarepta Therapeutics Company Details

11.12.2 Sarepta Therapeutics Business Overview

11.12.3 Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Introduction

11.12.4 Sarepta Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.12.5 Sarepta Therapeutics Recent Development

11.13 Carbon BioSciences

11.13.1 Carbon BioSciences Company Details

11.13.2 Carbon BioSciences Business Overview

11.13.3 Carbon BioSciences Adeno-Associated Virus Gene Therapy Introduction

11.13.4 Carbon BioSciences Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.13.5 Carbon BioSciences Recent Development

11.14 Kelonia Therapeutics

11.14.1 Kelonia Therapeutics Company Details

11.14.2 Kelonia Therapeutics Business Overview

11.14.3 Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Introduction

11.14.4 Kelonia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.14.5 Kelonia Therapeutics Recent Development

11.15 Roche

11.15.1 Roche Company Details

11.15.2 Roche Business Overview

11.15.3 Roche Adeno-Associated Virus Gene Therapy Introduction

11.15.4 Roche Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.15.5 Roche Recent Development

11.16 Remedium Bio

11.16.1 Remedium Bio Company Details

11.16.2 Remedium Bio Business Overview

11.16.3 Remedium Bio Adeno-Associated Virus Gene Therapy Introduction

11.16.4 Remedium Bio Revenue in Adeno-Associated Virus Gene Therapy Business (2021–2026)

11.16.5 Remedium Bio Recent Development

12. Analyst’s Viewpoints / Conclusions
13. Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Gene Silencing

Table 3. Key Players of Gene Replacement

Table 4. Key Players of Gene Addition

Table 5. Key Players of Gene Editing

Table 6. Global Adeno-Associated Virus Gene Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Adeno-Associated Virus Gene Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Adeno-Associated Virus Gene Therapy Market Size by Region (US$ Million), 2021–2026

Table 9. Global Adeno-Associated Virus Gene Therapy Market Share by Region (2021–2026)

Table 10. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Adeno-Associated Virus Gene Therapy Market Share by Region (2027–2032)

Table 12. Adeno-Associated Virus Gene Therapy Market Trends

Table 13. Adeno-Associated Virus Gene Therapy Market Drivers

Table 14. Adeno-Associated Virus Gene Therapy Market Challenges

Table 15. Adeno-Associated Virus Gene Therapy Market Restraints

Table 16. Global Adeno-Associated Virus Gene Therapy Revenue by Players (US$ Million), 2021–2026

Table 17. Global Adeno-Associated Virus Gene Therapy Market Share by Players (2021–2026)

Table 18. Global Top Adeno-Associated Virus Gene Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Adeno-Associated Virus Gene Therapy Revenue, 2025

Table 19. Ranking of Global Top Adeno-Associated Virus Gene Therapy Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Adeno-Associated Virus Gene Therapy Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Adeno-Associated Virus Gene Therapy, Headquarters and Area Served

Table 22. Global Key Players of Adeno-Associated Virus Gene Therapy, Products and Applications

Table 23. Global Key Players of Adeno-Associated Virus Gene Therapy, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Adeno-Associated Virus Gene Therapy Market Size by Type (US$ Million), 2021–2026

Table 26. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2021–2026)

Table 27. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2027–2032)

Table 29. Global Adeno-Associated Virus Gene Therapy Market Size by Application (US$ Million), 2021–2026

Table 30. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2021–2026)

Table 31. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2027–2032)

Table 33. North America Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Adeno-Associated Virus Gene Therapy Market Size by Country (US$ Million), 2021–2026

Table 35. North America Adeno-Associated Virus Gene Therapy Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Adeno-Associated Virus Gene Therapy Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Adeno-Associated Virus Gene Therapy Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (US$ Million), 2027–2032

Table 48. Creative Biolabs Company Details

Table 49. Creative Biolabs Business Overview

Table 50. Creative Biolabs Adeno-Associated Virus Gene Therapy Product

Table 51. Creative Biolabs Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 52. Creative Biolabs Recent Development

Table 53. Affinia Therapeutics Company Details

Table 54. Affinia Therapeutics Business Overview

Table 55. Affinia Therapeutics Adeno-Associated Virus Gene Therapy Product

Table 56. Affinia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 57. Affinia Therapeutics Recent Development

Table 58. Spark Therapeutics Company Details

Table 59. Spark Therapeutics Business Overview

Table 60. Spark Therapeutics Adeno-Associated Virus Gene Therapy Product

Table 61. Spark Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 62. Spark Therapeutics Recent Development

Table 63. AGC Biologics Company Details

Table 64. AGC Biologics Business Overview

Table 65. AGC Biologics Adeno-Associated Virus Gene Therapy Product

Table 66. AGC Biologics Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 67. AGC Biologics Recent Development

Table 68. StrideBio Company Details

Table 69. StrideBio Business Overview

Table 70. StrideBio Adeno-Associated Virus Gene Therapy Product

Table 71. StrideBio Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 72. StrideBio Recent Development

Table 73. SIRION Biotech Company Details

Table 74. SIRION Biotech Business Overview

Table 75. SIRION Biotech Adeno-Associated Virus Gene Therapy Product

Table 76. SIRION Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 77. SIRION Biotech Recent Development

Table 78. Neurophth Biotechnology Company Details

Table 79. Neurophth Biotechnology Business Overview

Table 80. Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Product

Table 81. Neurophth Biotechnology Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 82. Neurophth Biotechnology Recent Development

Table 83. Belief BioMed Company Details

Table 84. Belief BioMed Business Overview

Table 85. Belief BioMed Adeno-Associated Virus Gene Therapy Product

Table 86. Belief BioMed Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 87. Belief BioMed Recent Development

Table 88. BiBo Biopharma Engineering Co., Ltd. Company Details

Table 89. BiBo Biopharma Engineering Co., Ltd. Business Overview

Table 90. BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Product

Table 91. BiBo Biopharma Engineering Co., Ltd. Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 92. BiBo Biopharma Engineering Co., Ltd. Recent Development

Table 93. Beihai Kangcheng Company Details

Table 94. Beihai Kangcheng Business Overview

Table 95. Beihai Kangcheng Adeno-Associated Virus Gene Therapy Product

Table 96. Beihai Kangcheng Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 97. Beihai Kangcheng Recent Development

Table 98. PackGene Biotech Company Details

Table 99. PackGene Biotech Business Overview

Table 100. PackGene Biotech Adeno-Associated Virus Gene Therapy Product

Table 101. PackGene Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 102. PackGene Biotech Recent Development

Table 103. Sarepta Therapeutics Company Details

Table 104. Sarepta Therapeutics Business Overview

Table 105. Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Product

Table 106. Sarepta Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 107. Sarepta Therapeutics Recent Development

Table 108. Carbon BioSciences Company Details

Table 109. Carbon BioSciences Business Overview

Table 110. Carbon BioSciences Adeno-Associated Virus Gene Therapy Product

Table 111. Carbon BioSciences Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 112. Carbon BioSciences Recent Development

Table 113. Kelonia Therapeutics Company Details

Table 114. Kelonia Therapeutics Business Overview

Table 115. Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Product

Table 116. Kelonia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 117. Kelonia Therapeutics Recent Development

Table 118. Roche Company Details

Table 119. Roche Business Overview

Table 120. Roche Adeno-Associated Virus Gene Therapy Product

Table 121. Roche Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 122. Roche Recent Development

Table 123. Remedium Bio Company Details

Table 124. Remedium Bio Business Overview

Table 125. Remedium Bio Adeno-Associated Virus Gene Therapy Product

Table 126. Remedium Bio Revenue in Adeno-Associated Virus Gene Therapy Business (US$ Million), 2021–2026

Table 127. Remedium Bio Recent Development

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report



★調査レポート[アデノ随伴ウイルス遺伝子治療の世界市場2026年] (コード：QYR8003HN8835)販売に関する免責事項を必ずご確認ください。
★調査レポート[アデノ随伴ウイルス遺伝子治療の世界市場2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • アデノ随伴ウイルス遺伝子治療の世界市場（2026年～2036年）
  • リレーショナルデータベースソフトウェアの世界市場2026
  • ウイスキーの世界市場2026
  • 塩化ガリウムの世界市場2026年
  • 世界の電気ブッシング市場2026-2032
  • 世界のドローン用慣性計測装置（IMU）市場2026
  • MLCC用スクリーン印刷メッシュの世界市場2026
  • 臭化ガリウムの世界市場2026年
  • MTフェルールの世界市場2026
  • 世界の冷蔵コンテナ市場2026-2032

    • ◆H&Iグローバルリサーチのお客様（例）◆